Congestive heart failure is a chronic heart condition that usually occurs in older people However people with a history of ...
In a study published in Science, researchers reported that a single intramuscular injection helped mice and pigs recover after myocardial infarction, or heart attack. The treatment uses ...
A lot of the population through health education on radio and television stations, some health contents on social media, ...
BioCardia ®, Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its ...
Ferroptosis is a form of cell death driven by iron ions and lipid peroxidation. For the heart, this death process acts like a chain reaction, delivering an irreversible and devastating blow to ...
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
About 40% of East Asians suffer from alcohol intolerance, known as "Asian Flush Syndrome," caused by an ALDH2 genetic mutation. Beyond facial flushing, this mutation carries serious cardiovascular ...
Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to ...
Approximately 40% of the East Asian population suffers from alcohol intolerance, commonly known as "Asian Flush Syndrome". This ALDH2 genetic mutation ...
Remote ischaemic conditioning preserved cardiac function during anthracycline therapy without reducing tumour suppression.
BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and ...
Morning Overview on MSN
Study: GLP-1 drugs like Ozempic may limit heart damage after attack
Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results